|
1Z0M
the glycogen-binding domain of the AMP-activated protein kinase beta1 subunit
Deposited 2005-03-02
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
67–162(96 aa)
Fragment:68-163 of beta1 subunit
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;299 K;PEG, monomethyl ether 5000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K
|
Resolution 1.91 Å
R-free 0.243
|
|
1Z0M
the glycogen-binding domain of the AMP-activated protein kinase beta1 subunit
Deposited 2005-03-02
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
67–162(96 aa)
Fragment:68-163 of beta1 subunit
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;299 K;PEG, monomethyl ether 5000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K
|
Resolution 1.91 Å
R-free 0.243
|
|
1Z0M
the glycogen-binding domain of the AMP-activated protein kinase beta1 subunit
Deposited 2005-03-02
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
67–162(96 aa)
Fragment:68-163 of beta1 subunit
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;299 K;PEG, monomethyl ether 5000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K
|
Resolution 1.91 Å
R-free 0.243
|
|
1Z0N
the glycogen-binding domain of the AMP-activated protein kinase
Deposited 2005-03-02
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
67–162(96 aa)
Fragment:68-163 fragment
|
Mutation:L105M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;299 K;PEG, monomethyl ether 5000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K
|
Resolution 1.49 Å
R-free 0.213
|
|
1Z0N
the glycogen-binding domain of the AMP-activated protein kinase
Deposited 2005-03-02
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
67–162(96 aa)
Fragment:68-163 fragment
|
Mutation:L105M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;299 K;PEG, monomethyl ether 5000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K
|
Resolution 1.49 Å
R-free 0.213
|
|
1Z0N
the glycogen-binding domain of the AMP-activated protein kinase
Deposited 2005-03-02
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
67–162(96 aa)
Fragment:68-163 fragment
|
Mutation:L105M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;299 K;PEG, monomethyl ether 5000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 299K
|
Resolution 1.49 Å
R-free 0.213
|
|
4EAG
Co-crystal structure of an chimeric AMPK core with ATP
Deposited 2012-03-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
187–270(84 aa)
Fragment:UNP residues 187-270
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.02;298 K;MES, 12% Methanol, 2% 1,4-butanodiol, pH 6.02 , VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.70 Å
R-free 0.252
|
|
4EAK
Co-crystal structure of an AMPK core with ATP
Deposited 2012-03-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
200–270(71 aa)
Fragment:UNP residues 200-270
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
TAM TRIS(HYDROXYETHYL)AMINOMETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.9;298 K;0.1M MES pH 5.9, 18% IPP, VAPOR DIFFUSION, HANGING DROP, temperature 298 K
|
Resolution 2.50 Å
R-free 0.254
|
|
4EAL
Co-crystal of AMPK core with ATP soaked with AMP
Deposited 2012-03-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
200–270(71 aa)
Fragment:UNP residues 200-270
|
Not recorded
|
AMP ADENOSINE MONOPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.9;298 K;0.1M MES pH5.9, 18% IPP, pH 5.9, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.51 Å
R-free 0.277
|
|
4QFG
Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator
Deposited 2014-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
67–269(203 aa)
Fragment:AMPK beta1
|
Mutation:S108D
|
STU STAUROSPORINE × 1
CL CHLORIDE ION × 3
SO4 SULFATE ION × 3
AMP ADENOSINE MONOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 3.46 Å
R-free 0.267
|
|
4QFG
Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator
Deposited 2014-05-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
67–269(203 aa)
Fragment:AMPK beta1
|
Mutation:S108D
|
STU STAUROSPORINE × 2
CL CHLORIDE ION × 6
SO4 SULFATE ION × 6
AMP ADENOSINE MONOPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene Glycol, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 3.46 Å
R-free 0.267
|
|
4QFR
Structure of AMPK in complex with Cl-A769662 activator and STAUROSPORINE inhibitor
Deposited 2014-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
Fragment:AMPK beta 1
|
Mutation:S108D
|
STU STAUROSPORINE × 1
CL CHLORIDE ION × 5
32J 2-chloro-4-hydroxy-3-(2'-hydroxybiphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile × 1
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 3.34 Å
R-free 0.249
|
|
4QFR
Structure of AMPK in complex with Cl-A769662 activator and STAUROSPORINE inhibitor
Deposited 2014-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
Fragment:AMPK beta 1
|
Mutation:S108D
|
STU STAUROSPORINE × 2
CL CHLORIDE ION × 10
32J 2-chloro-4-hydroxy-3-(2'-hydroxybiphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile × 2
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 3.34 Å
R-free 0.249
|
|
4QFR
Structure of AMPK in complex with Cl-A769662 activator and STAUROSPORINE inhibitor
Deposited 2014-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
Fragment:AMPK beta 1
|
Mutation:S108D
|
STU STAUROSPORINE × 2
CL CHLORIDE ION × 10
32J 2-chloro-4-hydroxy-3-(2'-hydroxybiphenyl-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile × 2
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 3.34 Å
R-free 0.249
|
|
4QFS
Structure of AMPK in complex with Br2-A769662core activator and STAUROSPORINE inhibitor
Deposited 2014-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
Fragment:AMPK beta 1
|
Mutation:S108D
|
STU STAUROSPORINE × 1
32H 2-bromo-3-(4-bromophenyl)-4-hydroxy-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile × 1
CL CHLORIDE ION × 5
AMP ADENOSINE MONOPHOSPHATE × 1
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.55 Å
R-free 0.269
|
|
4QFS
Structure of AMPK in complex with Br2-A769662core activator and STAUROSPORINE inhibitor
Deposited 2014-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
Fragment:AMPK beta 1
|
Mutation:S108D
|
STU STAUROSPORINE × 2
32H 2-bromo-3-(4-bromophenyl)-4-hydroxy-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile × 2
CL CHLORIDE ION × 10
AMP ADENOSINE MONOPHOSPHATE × 2
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;750 mM Ammonium Sulfate, 500 mM Lithium Sulfate, 100 mM tri-Sodium Citrate, 1% Ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 3.55 Å
R-free 0.269
|
|
5KQ5
AMPK bound to allosteric activator
Deposited 2016-07-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
Fragment:residues 68-270
|
Mutation:S108D
|
STU STAUROSPORINE × 1
6VT 6-chloranyl-5-[4-(1-oxidanylcyclobutyl)phenyl]-1~{H}-indole-3-carboxylic acid × 1
CL CHLORIDE ION × 4
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;~750 mM Ammonium Acetate, 500 mM Lithium Sulfate, 100 mM trisodium citrate, 1% ethylene glycol
|
Resolution 3.41 Å
R-free 0.259
|
|
5T5T
AMPK bound to allosteric activator
Deposited 2016-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
|
Mutation:S108D, Q109H
|
STU STAUROSPORINE × 1
CL CHLORIDE ION × 3
SO4 SULFATE ION × 2
75O 6-chloro-5-[6-(dimethylamino)-2-methoxypyridin-3-yl]-1H-indole-3-carboxylic acid × 1
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;100 mM trisodium citrate, 500 mM ammonium sulfate, 900 mM lithium sulfate, and 4% glycerol
|
Resolution 3.46 Å
R-free 0.231
|
|
5T5T
AMPK bound to allosteric activator
Deposited 2016-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
|
Mutation:S108D, Q109H
|
STU STAUROSPORINE × 2
CL CHLORIDE ION × 6
SO4 SULFATE ION × 4
75O 6-chloro-5-[6-(dimethylamino)-2-methoxypyridin-3-yl]-1H-indole-3-carboxylic acid × 2
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;100 mM trisodium citrate, 500 mM ammonium sulfate, 900 mM lithium sulfate, and 4% glycerol
|
Resolution 3.46 Å
R-free 0.231
|
|
5UFU
Structure of AMPK bound to activator
Deposited 2017-01-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
|
Not recorded
|
STU STAUROSPORINE × 1
85V 1,4:3,6-dianhydro-2-O-(6-chloro-5-{4-[1-(hydroxymethyl)cyclopropyl]phenyl}-1H-benzimidazol-2-yl)-D-mannitol × 1
CL CHLORIDE ION × 3
SO4 SULFATE ION × 2
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 mM ammonium sulfate
500 mM lithium sulfate
100 mM trisodium citrate
1% ethylene glycol
|
Resolution 3.45 Å
R-free 0.238
|
|
5UFU
Structure of AMPK bound to activator
Deposited 2017-01-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
|
Not recorded
|
STU STAUROSPORINE × 2
85V 1,4:3,6-dianhydro-2-O-(6-chloro-5-{4-[1-(hydroxymethyl)cyclopropyl]phenyl}-1H-benzimidazol-2-yl)-D-mannitol × 2
CL CHLORIDE ION × 6
SO4 SULFATE ION × 4
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 mM ammonium sulfate
500 mM lithium sulfate
100 mM trisodium citrate
1% ethylene glycol
|
Resolution 3.45 Å
R-free 0.238
|
|
6E4T
Structure of AMPK bound to activator
Deposited 2018-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HTV 1-O-{6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carbonyl}-beta-D-glucopyranuronic acid × 1
STU STAUROSPORINE × 1
CL CHLORIDE ION × 5
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 MM AMMONIUM SULFATE, 500 MM LITHIUM SULFATE, 100 MM TRISODIUM CITRATE, 1% ETHYLENE GLYCOL
|
Resolution 3.40 Å
R-free 0.245
|
|
6E4T
Structure of AMPK bound to activator
Deposited 2018-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
HTV 1-O-{6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carbonyl}-beta-D-glucopyranuronic acid × 2
STU STAUROSPORINE × 2
CL CHLORIDE ION × 10
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 MM AMMONIUM SULFATE, 500 MM LITHIUM SULFATE, 100 MM TRISODIUM CITRATE, 1% ETHYLENE GLYCOL
|
Resolution 3.40 Å
R-free 0.245
|
|
6E4U
Structure of AMPK bound to activator
Deposited 2018-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
STU STAUROSPORINE × 1
HU7 1-O-{6-chloro-5-[6-(dimethylamino)-2-methoxypyridin-3-yl]-1H-indole-3-carbonyl}-beta-D-glucopyranuronic acid × 1
CL CHLORIDE ION × 4
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 MM AMMONIUM SULFATE, 500 MM LITHIUM SULFATE, 100 MM TRISODIUM CITRATE, 1% ETHYLENE GLYCOL
|
Resolution 3.27 Å
R-free 0.231
|
|
6E4U
Structure of AMPK bound to activator
Deposited 2018-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
STU STAUROSPORINE × 2
HU7 1-O-{6-chloro-5-[6-(dimethylamino)-2-methoxypyridin-3-yl]-1H-indole-3-carbonyl}-beta-D-glucopyranuronic acid × 2
CL CHLORIDE ION × 8
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 MM AMMONIUM SULFATE, 500 MM LITHIUM SULFATE, 100 MM TRISODIUM CITRATE, 1% ETHYLENE GLYCOL
|
Resolution 3.27 Å
R-free 0.231
|
|
6E4W
Structure of AMPK bound to activator
Deposited 2018-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
68–270(203 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
STU STAUROSPORINE × 1
HUG 1-O-(4,6-difluoro-5-{4-[(2S)-oxan-2-yl]phenyl}-1H-indole-3-carbonyl)-beta-D-glucopyranuronic acid × 1
CL CHLORIDE ION × 3
AMP ADENOSINE MONOPHOSPHATE × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 MM AMMONIUM SULFATE, 500 MM LITHIUM SULFATE, 100 MM TRISODIUM CITRATE, 1% ETHYLENE GLYCOL
|
Resolution 3.35 Å
R-free 0.244
|
|
6E4W
Structure of AMPK bound to activator
Deposited 2018-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
68–270(203 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
STU STAUROSPORINE × 2
HUG 1-O-(4,6-difluoro-5-{4-[(2S)-oxan-2-yl]phenyl}-1H-indole-3-carbonyl)-beta-D-glucopyranuronic acid × 2
CL CHLORIDE ION × 6
AMP ADENOSINE MONOPHOSPHATE × 4
ADP ADENOSINE-5'-DIPHOSPHATE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;750 MM AMMONIUM SULFATE, 500 MM LITHIUM SULFATE, 100 MM TRISODIUM CITRATE, 1% ETHYLENE GLYCOL
|
Resolution 3.35 Å
R-free 0.244
|